13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000905148-25-002929
Total Value
$114.8M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | PHARVARIS N V | PHVS | 4,289,304 | $75.5M | 65.78% |
| 2 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 489,194 | $15.5M | 13.47% |
| 3 | ALUMIS INC | ALMS | 4,619,803 | $13.9M | 12.08% |
| 4 | LYELL IMMUNOPHARMA INC | LYEL | 473,479 | $4.2M | 3.65% |
| 5 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $4.0M | 3.51% |
| 6 | ARTIVA BIOTHERAPEUTICS INC | ARTV | 1,148,975 | $1.7M | 1.51% |